BetterLife Pharma (STU:NPAU) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:NPAU BetterLife Pharma Inc STU:NPAU
31 GF Score
Price €0.11
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:NPAU vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, BetterLife Pharma's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BetterLife Pharma Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Short Interest distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Short Interest falls into.


STU:NPAU
31GF Score
BetterLife Pharma Inc STU:NPAU
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Business Description

Other Exchanges BETRF:USABETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
31GF Score

Get the complete analysis for STU:NPAU

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price